Skip to main content
Erschienen in: Clinical Oral Investigations 1/2003

01.03.2003 | CONSORT statement

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials

verfasst von: David Moher, Kenneth F. Schulz, Douglas G. Altman, for the CONSORT Group*

Erschienen in: Clinical Oral Investigations | Ausgabe 1/2003

Einloggen, um Zugang zu erhalten

Abstract

To comprehend the results of a randomised controlled trial (RCT), readers must understand its design, conduct, analysis, and interpretation. That goal can be achieved only through total transparency from authors. Despite several decades of educational efforts, the reporting of RCTs needs improvement. Investigators and editors developed the original CONSORT (Consolidated Standards of Reporting Trials) statement to help authors improve reporting by use of a checklist and flow diagram. The revised CONSORT statement presented here incorporates new evidence and addresses some criticisms of the original statement. The checklist items pertain to the content of the Title, Abstract, Introduction, Methods, Results, and Discussion. The revised checklist includes 22 items selected because empirical evidence indicates that not reporting this information is associated with biased estimates of treatment effect, or because the information is essential to judge the reliability or relevance of the findings. We intended the flow diagram to depict the passage of participants through an RCT. The revised flow diagram depicts information from four stages of a trial (enrolment, intervention allocation, follow- up, and analysis). The diagram explicitly shows the number of participants, for each intervention group, included in the primary data analysis. Inclusion of these numbers allows the reader to judge whether the authors have done an intention- to-treat analysis. In sum, the CONSORT statement is intended to improve the reporting of an RCT, enabling readers to understand a trial's conduct and to assess the validity of its results.
Literatur
1.
Zurück zum Zitat Schulz KF, Chalmers I, Hayes RJ, Altman DG (1995) Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 273: 408–412PubMed Schulz KF, Chalmers I, Hayes RJ, Altman DG (1995) Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 273: 408–412PubMed
2.
Zurück zum Zitat Moher D, Pham B, Jones A et al (1998) Does the quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 352: 609–613PubMed Moher D, Pham B, Jones A et al (1998) Does the quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 352: 609–613PubMed
3.
Zurück zum Zitat Jadad AR, Boyle M, Cunningham C, Kim M, Schachar R (2000) Treatment of attention deficit/hyperactivity disorder: evidence report/technology assessment no. 11. McMaster University, Hamilton Jadad AR, Boyle M, Cunningham C, Kim M, Schachar R (2000) Treatment of attention deficit/hyperactivity disorder: evidence report/technology assessment no. 11. McMaster University, Hamilton
4.
Zurück zum Zitat Thornley B, Adams CE (1998) Content and quality of 2000 controlled trials in schizophrenia over 50 years. BMJ 317: 1181–1184PubMed Thornley B, Adams CE (1998) Content and quality of 2000 controlled trials in schizophrenia over 50 years. BMJ 317: 1181–1184PubMed
5.
Zurück zum Zitat Hotopf M, Lewis G, Normand C (1997) Putting trials on trial-the costs and consequences of small trials in depression: a systematic review of methodology. J Epidemiol Community Health 51: 354–358PubMed Hotopf M, Lewis G, Normand C (1997) Putting trials on trial-the costs and consequences of small trials in depression: a systematic review of methodology. J Epidemiol Community Health 51: 354–358PubMed
6.
Zurück zum Zitat Dickinson K, Bunn F, Wentz R, Edwards P, Roberts I (2000) Size and quality of randomised controlled trials in head injury: review of published studies. BMJ 320: 1308–1311CrossRef Dickinson K, Bunn F, Wentz R, Edwards P, Roberts I (2000) Size and quality of randomised controlled trials in head injury: review of published studies. BMJ 320: 1308–1311CrossRef
7.
Zurück zum Zitat Begg CB, Cho MK, Eastwood S et al (1996) Improving the quality of reporting of randomized controlled trials: the CONSORT statement. JAMA 276: 637–639PubMed Begg CB, Cho MK, Eastwood S et al (1996) Improving the quality of reporting of randomized controlled trials: the CONSORT statement. JAMA 276: 637–639PubMed
8.
Zurück zum Zitat Freemantle N, Mason JM, Haines A, Eccles MP (1997) CONSORT: an important step toward evidence-based health care. Ann Intern Med 126: 81–83PubMed Freemantle N, Mason JM, Haines A, Eccles MP (1997) CONSORT: an important step toward evidence-based health care. Ann Intern Med 126: 81–83PubMed
9.
Zurück zum Zitat Altman DG (1996) Better reporting of randomized controlled trials: the CONSORT statement. BMJ 313: 570–571PubMed Altman DG (1996) Better reporting of randomized controlled trials: the CONSORT statement. BMJ 313: 570–571PubMed
10.
Zurück zum Zitat Schulz KF (1997) The quest for unbiased research: randomized clinical trials and the CONSORT reporting guidelines. Ann Neurol 41: 569–573PubMed Schulz KF (1997) The quest for unbiased research: randomized clinical trials and the CONSORT reporting guidelines. Ann Neurol 41: 569–573PubMed
11.
Zurück zum Zitat Huston P, Hoey J (1996) CMAJ endorses the CONSORT statement. Can Med Assoc J 155: 1277–1279 Huston P, Hoey J (1996) CMAJ endorses the CONSORT statement. Can Med Assoc J 155: 1277–1279
12.
Zurück zum Zitat Davidoff F (2000) News from the International Committee of Medical Journal Editors. Ann Intern Med 133: 229–231PubMed Davidoff F (2000) News from the International Committee of Medical Journal Editors. Ann Intern Med 133: 229–231PubMed
13.
Zurück zum Zitat www.consort-statement.org (accessed 15 February 2001) www.consort-statement.org (accessed 15 February 2001)
14.
Zurück zum Zitat Moher D, Jones A, Lepage L, for the CONSORT Group (in press) Use of CONSORT statement and quality of reports of randomized trials: a comparative before and after evaluation? JAMA Moher D, Jones A, Lepage L, for the CONSORT Group (in press) Use of CONSORT statement and quality of reports of randomized trials: a comparative before and after evaluation? JAMA
15.
Zurück zum Zitat Egger M, Juni P, Bartiett C, for the CONSORT Group (in press) The value of patient flow charts in reports of randomized controlled trials: bibliographic study. JAMA Egger M, Juni P, Bartiett C, for the CONSORT Group (in press) The value of patient flow charts in reports of randomized controlled trials: bibliographic study. JAMA
16.
Zurück zum Zitat Meinert CL (1998) Beyond CONSORT: need for improved reporting standards for clinical trials. JAMA 279: 1487–1489PubMed Meinert CL (1998) Beyond CONSORT: need for improved reporting standards for clinical trials. JAMA 279: 1487–1489PubMed
17.
Zurück zum Zitat Chalmers I (2000) Current controlled trials: an opportunity to help improve the quality of clinical research. Curr Control Trials Cardiovasc Med 1: 3–8CrossRefPubMed Chalmers I (2000) Current controlled trials: an opportunity to help improve the quality of clinical research. Curr Control Trials Cardiovasc Med 1: 3–8CrossRefPubMed
18.
Zurück zum Zitat Bailer JC III, Mosteller F (1988) Guidelines for statistical reporting in articles for medical journals: amplifications and explanations. Ann Intern Med 108: 266–273PubMed Bailer JC III, Mosteller F (1988) Guidelines for statistical reporting in articles for medical journals: amplifications and explanations. Ann Intern Med 108: 266–273PubMed
19.
Zurück zum Zitat Altman DG, Schulz KF, Moher D et al, for the CONSORT group (2001) The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 134: 663–694PubMed Altman DG, Schulz KF, Moher D et al, for the CONSORT group (2001) The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 134: 663–694PubMed
20.
Zurück zum Zitat Elbourne DR, Campbell MK (in press) Extending the CONSORT statement to cluster randomised trials: for discussion. Stat Med Elbourne DR, Campbell MK (in press) Extending the CONSORT statement to cluster randomised trials: for discussion. Stat Med
21.
Zurück zum Zitat Hollis S, Campbell F (1999) What is meant by intention-to-treat analysis? Survey of published randomized controlled trials. BMJ 319: 670–674PubMed Hollis S, Campbell F (1999) What is meant by intention-to-treat analysis? Survey of published randomized controlled trials. BMJ 319: 670–674PubMed
22.
Zurück zum Zitat Ruiz-Canela M, Martinez-Gonzalez MA, de Irala-Estevez J (2000) Intention- to-treat analysis is related to methodological quality. BMJ 320: 1007CrossRef Ruiz-Canela M, Martinez-Gonzalez MA, de Irala-Estevez J (2000) Intention- to-treat analysis is related to methodological quality. BMJ 320: 1007CrossRef
23.
Zurück zum Zitat Lee YJ, Ellenberg JH, Hirtz DG, Nelson KB (1991) Analysis of clinical trials by treatment actually received: is it really an option? Stat Med 10: 1595–1605PubMed Lee YJ, Ellenberg JH, Hirtz DG, Nelson KB (1991) Analysis of clinical trials by treatment actually received: is it really an option? Stat Med 10: 1595–1605PubMed
24.
Zurück zum Zitat Bentzen SM (1998) Towards evidence-based radiation oncology: improving the design, analysis, and reporting of clinical outcome studies in radiotherapy. Radiother Oncol 46: 5–18CrossRefPubMed Bentzen SM (1998) Towards evidence-based radiation oncology: improving the design, analysis, and reporting of clinical outcome studies in radiotherapy. Radiother Oncol 46: 5–18CrossRefPubMed
25.
Zurück zum Zitat O'Toole LB (1997) MRC uses checklist similar to CONSORT's. BMJ 314: 1127 O'Toole LB (1997) MRC uses checklist similar to CONSORT's. BMJ 314: 1127
26.
Zurück zum Zitat Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF, for the QUOROM group (1999) Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Lancet 354: 1896–1900CrossRefPubMed Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF, for the QUOROM group (1999) Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Lancet 354: 1896–1900CrossRefPubMed
27.
Zurück zum Zitat Stroup DF, Berlin IA, Morton SC et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 283: 2008–2012PubMed Stroup DF, Berlin IA, Morton SC et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 283: 2008–2012PubMed
28.
Zurück zum Zitat Siegel IE, Weinstein MC, Russell LB, Gold MR (1996) Recommendations for reporting cost-effectiveness analysis. JAMA 276: 1339–1341PubMed Siegel IE, Weinstein MC, Russell LB, Gold MR (1996) Recommendations for reporting cost-effectiveness analysis. JAMA 276: 1339–1341PubMed
29.
Zurück zum Zitat Neumann PJ, Stone PW, Chapman RH, Sandberg EA, Bell CM (2000) The quality of reporting in published cost-utility analyses, 1976–1997. Ann Intern Med 132: 964–972PubMed Neumann PJ, Stone PW, Chapman RH, Sandberg EA, Bell CM (2000) The quality of reporting in published cost-utility analyses, 1976–1997. Ann Intern Med 132: 964–972PubMed
30.
Zurück zum Zitat Altman DG (1994) The scandal of poor medical research. BMJ 308: 283–284PubMed Altman DG (1994) The scandal of poor medical research. BMJ 308: 283–284PubMed
Metadaten
Titel
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials
verfasst von
David Moher
Kenneth F. Schulz
Douglas G. Altman
for the CONSORT Group*
Publikationsdatum
01.03.2003
Verlag
Springer-Verlag
Erschienen in
Clinical Oral Investigations / Ausgabe 1/2003
Print ISSN: 1432-6981
Elektronische ISSN: 1436-3771
DOI
https://doi.org/10.1007/s00784-002-0188-x

Weitere Artikel der Ausgabe 1/2003

Clinical Oral Investigations 1/2003 Zur Ausgabe

Calendar of events

March 2003

Parodontalbehandlung verbessert Prognose bei Katheterablation

19.04.2024 Vorhofflimmern Nachrichten

Werden Personen mit Vorhofflimmern in der Blanking-Periode nach einer Katheterablation gegen eine bestehende Parodontitis behandelt, verbessert dies die Erfolgsaussichten. Dafür sprechen die Resultate einer prospektiven Untersuchung.

Invasive Zahnbehandlung: Wann eine Antibiotikaprophylaxe vor infektiöser Endokarditis schützt

11.04.2024 Endokarditis Nachrichten

Bei welchen Personen eine Antibiotikaprophylaxe zur Prävention einer infektiösen Endokarditis nach invasiven zahnärztlichen Eingriffen sinnvoll ist, wird diskutiert. Neue Daten stehen im Einklang mit den europäischen Leitlinienempfehlungen.

Zell-Organisatoren unter Druck: Mechanismen des embryonalen Zahnwachstums aufgedeckt

08.04.2024 Zahnmedizin Nachrichten

Der Aufbau von Geweben und Organen während der Embryonalentwicklung wird von den Zellen bemerkenswert choreografiert. Für diesen Prozess braucht es spezielle sogenannte „Organisatoren“. In einer aktuellen Veröffentlichung im Fachjournal Nature Cell Biology berichten Forschende durch welchen Vorgang diese Organisatoren im Gewebe entstehen und wie sie dann die Bildung von Zähnen orchestrieren.

Die Oralprophylaxe & Kinderzahnheilkunde umbenannt

11.03.2024 Kinderzahnmedizin Nachrichten

Infolge der Umbenennung der Deutschen Gesellschaft für Kinderzahnheilkunde in Deutsche Gesellschaft für Kinderzahnmedizin (DGKiZ) wird deren Mitgliederzeitschrift Oralprophylaxe & Kinderzahnheilkunde in Oralprophylaxe & Kinderzahnmedizin umbenannt. Aus diesem Grunde trägt die erste Ausgabe in 2024 erstmalig den neuen Titel.

Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Zahnmedizin und bleiben Sie gut informiert – ganz bequem per eMail.